» Articles » PMID: 39232809

Heat Shock Proteins As Hallmarks of Cancer: Insights from Molecular Mechanisms to Therapeutic Strategies

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2024 Sep 5
PMID 39232809
Authors
Affiliations
Soon will be listed here.
Abstract

Heat shock proteins are essential molecular chaperones that play crucial roles in stabilizing protein structures, facilitating the repair or degradation of damaged proteins, and maintaining proteostasis and cellular functions. Extensive research has demonstrated that heat shock proteins are highly expressed in cancers and closely associated with tumorigenesis and progression. The "Hallmarks of Cancer" are the core features of cancer biology that collectively define a series of functional characteristics acquired by cells as they transition from a normal state to a state of tumor growth, including sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, enabled replicative immortality, the induction of angiogenesis, and the activation of invasion and metastasis. The pivotal roles of heat shock proteins in modulating the hallmarks of cancer through the activation or inhibition of various signaling pathways has been well documented. Therefore, this review provides an overview of the roles of heat shock proteins in vital biological processes from the perspective of the hallmarks of cancer and summarizes the small-molecule inhibitors that target heat shock proteins to regulate various cancer hallmarks. Moreover, we further discuss combination therapy strategies involving heat shock proteins and promising dual-target inhibitors to highlight the potential of targeting heat shock proteins for cancer treatment. In summary, this review highlights how targeting heat shock proteins could regulate the hallmarks of cancer, which will provide valuable information to better elucidate and understand the roles of heat shock proteins in oncology and the mechanisms of cancer occurrence and development and aid in the development of more efficacious and less toxic novel anticancer agents.

Citing Articles

Transcriptomics Unveil Canonical and Non-Canonical Heat Shock-Induced Pathways in Human Cell Lines.

Reinschmidt A, Solano L, Chavez Y, Hulsy W, Nikolaidis N Int J Mol Sci. 2025; 26(3).

PMID: 39940831 PMC: 11816735. DOI: 10.3390/ijms26031057.


A new weapon: the application of tumor vaccines based on extracellular exosomal heat shock proteins in immunotherapy.

Yi K, Sun C, Yuan Y, Luo Z, Luo H, Xie Y Front Immunol. 2025; 16:1510650.

PMID: 39911383 PMC: 11794256. DOI: 10.3389/fimmu.2025.1510650.


Exosome: an overview on enhanced biogenesis by small molecules.

Bavafa A, Izadpanahi M, Hosseini E, Hajinejad M, Abedi M, Forouzanfar F Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39862264 DOI: 10.1007/s00210-024-03762-9.


Affordable mRNA Novel Proteins, Recombinant Protein Conversions, and Biosimilars-Advice to Developers and Regulatory Agencies.

Niazi S Biomedicines. 2025; 13(1).

PMID: 39857681 PMC: 11760483. DOI: 10.3390/biomedicines13010097.


Transcriptomics Unveil Canonical and Non-Canonical Heat Shock-Induced Pathways in Human Cell Lines.

Reinschmidt A, Solano L, Chavez Y, Hulsy W, Nikolaidis N bioRxiv. 2025; .

PMID: 39763846 PMC: 11703194. DOI: 10.1101/2024.12.22.629972.

References
1.
Yun C, Kim H, Lim J, Lee S . Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy. Cells. 2019; 9(1). PMC: 7017199. DOI: 10.3390/cells9010060. View

2.
Balogi Z, Multhoff G, Jensen T, Lloyd-Evans E, Yamashima T, Jaattela M . Hsp70 interactions with membrane lipids regulate cellular functions in health and disease. Prog Lipid Res. 2019; 74:18-30. DOI: 10.1016/j.plipres.2019.01.004. View

3.
Rashmi K, Atreya H, Harsha Raj M, Salimath B, Aparna H . A pyrrole-based natural small molecule mitigates HSP90 expression in MDA-MB-231 cells and inhibits tumor angiogenesis in mice by inactivating HSF-1. Cell Stress Chaperones. 2017; 22(5):751-766. PMC: 5573693. DOI: 10.1007/s12192-017-0802-0. View

4.
Hartmann M, Bibli S, Tews D, Ni X, Kircher T, Kramer J . Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator. J Med Chem. 2021; 64(5):2815-2828. DOI: 10.1021/acs.jmedchem.0c02063. View

5.
Ahsan R, Muazzam Khan M, Mishra A, Noor G, Ahmad U . Protein Kinases and their Inhibitors Implications in Modulating Disease Progression. Protein J. 2023; 42(6):621-632. DOI: 10.1007/s10930-023-10159-9. View